Text to be removed highlighted in red.
210:1 New Section; Controlled Drugs Containing Opiates; Warning Label Required. Amend RSA 318-B by inserting after section 16 the following new section:
318-B:16-a Controlled Drugs Containing Opiates; Warning Label Required. Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have an orange sticker with the word "opioid" in easily legible font placed on the cap or dispenser and shall have a warning label stating "Risk of addiction and overdose." The health care provider or pharmacist shall also provide each person with a handout which shall be developed and approved by the governor's commission on alcohol and drug abuse, prevention, treatment, and recovery which shall include guidance on associated risks of opioid use and how to mitigate them. This section shall not apply to pharmacists or a pharmacy that dispenses a drug containing an opioid that is administered to a patient treated in a health care facility required to be licensed under RSA 151. A patient may remove the cap sticker or warning label.
210:2 New Paragraph; Governor's Commission on Alcohol and Drug Abuse, Prevention, Treatment, and Recovery; Duties. Amend RSA 12-J:3 by inserting after paragraph VI the following new paragraph:
VII. Develop a handout which shall describe the risks of opioid use and how to mitigate them for the purposes of RSA 318-B:16-a.
210:3 Effective Date. This act shall take effect January 1, 2020.
Approved: July 12, 2019
Effective Date: January 01, 2020
Text to be added highlighted in green.
210:1 New Section; Controlled Drugs Containing Opiates; Warning Label Required. Amend RSA 318-B by inserting after section 16 the following new section:
318-B:16-a Controlled Drugs Containing Opiates; Warning Label Required. Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have an orange sticker with the word "opioid" in easily legible font placed on the cap or dispenser and shall have a warning label stating "Risk of addiction and overdose." The health care provider or pharmacist shall also provide each person with a handout which shall be developed and approved by the governor's commission on alcohol and drug abuse, prevention, treatment, and recovery which shall include guidance on associated risks of opioid use and how to mitigate them. This section shall not apply to pharmacists or a pharmacy that dispenses a drug containing an opioid that is administered to a patient treated in a health care facility required to be licensed under RSA 151. A patient may remove the cap sticker or warning label.
210:2 New Paragraph; Governor's Commission on Alcohol and Drug Abuse, Prevention, Treatment, and Recovery; Duties. Amend RSA 12-J:3 by inserting after paragraph VI the following new paragraph:
VII. Develop a handout which shall describe the risks of opioid use and how to mitigate them for the purposes of RSA 318-B:16-a.
210:3 Effective Date. This act shall take effect January 1, 2020.
Approved: July 12, 2019
Effective Date: January 01, 2020